Toxicity Evaluations of Superparamagnetic Iron Oxide Nanoparticles: Cell “Vision” versus Physicochemical Properties of Nanoparticles
Source abstract
Abstract
In the last few decades, nanoparticles (NPs) have been recognized as promising candidates for starting a new revolution in science and technology due to their unusual properties, attracting the attention of physicists, chemists, biologists, and engineers. The aim of this study is to evaluate the toxicities (at both cellular and molecular levels) of three forms of superparamagnetic iron oxide nanoparticles (SPIONs) of various surface chemistries (COOH, plain, and NH(2)) through the comparison with gene expression patterns of three cell types (i.e., human heart, brain, and kidney). For this purpose, both an MTT assay and a DNA microarray analysis were applied in three human cell lines--HCM (heart), BE-2-C (brain), and 293T (kidney)--under the exposure to SPIONs-COOH, SPIONs-NH(2), and bare SPIONs. The specific gene alteration and hierarchical clustering revealed that SPIONs-COOH altered genes associated with cell proliferative responses due to their reactive oxygen species (ROS) properties. It was also found that the cell type can have quite a significant role in the definition of suitable pathways for detoxification of NPs, which has deep implications for the safe and high yield design of NPs for biomedical applications and will require serious consideration in the future.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
National Cell Bank, Pasteur Institute of Iran, Tehran, 1316943551 Iran
Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Department of General, Organic, and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, University of Mons, Avenue Maistriau, 19, B-7000 Mons, Belgium
Cardiovascular Research Center, Mount Sinai School of Medicine, New York, New York 10029, United States
National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
References (59)
Show source-provided references
1. Mahmoudi M. · Chem. Rev. · 2011 · 111 · 25310.1021/cr1001832 ↗
2. Mahmoudi M. · Adv. Drug Delivery Rev. · 2011 · 63 · 2410.1016/j.addr.2010.05.006 ↗
3. Laurent S. · Adv. Colloid Interface Sci. · 2011 · 166 · 810.1016/j.cis.2011.04.003 ↗
4. Mailander V. · Mol. Imaging Biol. · 2008 · 10 · 13810.1007/s11307-007-0130-3 ↗
5. Gupta A. K. · Nanomedicine · 2007 · 2 · 2310.2217/17435889.2.1.23 ↗
6. Aillon K. L. · Adv. Drug Delivery Rev. · 2009 · 61 · 45710.1016/j.addr.2009.03.010 ↗
7. Karlsson H. L. · Chem. Res. Toxicol. · 2008 · 21 · 172610.1021/tx800064j ↗
8. Gupta A. K. · IEEE Trans. Nanobiosci. · 2003 · 2 · 25610.1109/TNB.2003.820279 ↗
9. Gupta A. K. · IEEE Trans. Nanobiosci. · 2004 · 3 · 6610.1109/TNB.2003.820277 ↗
10. Mahmoudi M. · J. Phys. Chem. C · 2009 · 113 · 232210.1021/jp809453v ↗
11. Mahmoudi M. · J. Phys. Chem. C · 2009 · 113 · 957310.1021/jp9001516 ↗
12. Mahmoudi M. · Adv. Eng. Mater. · 2009 · 11 · B24310.1002/adem.200990035 ↗
13. Hussain S. M. · Toxicol. in Vitro · 2005 · 19 · 97510.1016/j.tiv.2005.06.034 ↗
14. Arbab A. S. · Radiology · 2003 · 229 · 83810.1148/radiol.2293021215 ↗
15. Arbab A. S. · Mol. Imaging · 2004 · 3 · 2410.1162/153535004773861697 ↗
16. Cheng C. M. · Cancer Gene Ther. · 2009 · 16 · 8310.1038/cgt.2008.50 ↗
17. Cheng F. Y. · Biomaterials · 2005 · 26 · 72910.1016/j.biomaterials.2004.03.016 ↗
18. Brunner T. J. · Environ. Sci. Technol. · 2006 · 40 · 437410.1021/es052069i ↗
19. Lee C. M. · Macromol. Res. · 2009 · 17 · 13310.1007/BF03218667 ↗
20. Lee C. M. · Int. J. Pharm. · 2009 · 371 · 16310.1016/j.ijpharm.2008.12.021 ↗
21. Lee H. · J. Am. Chem. Soc. · 2006 · 128 · 738310.1021/ja061529k ↗
22. Raty J. K. · Gene Ther. · 2006 · 13 · 144010.1038/sj.gt.3302828 ↗
23. Kim J. S. · J. Vet. Sci. · 2006 · 7 · 32110.4142/jvs.2006.7.4.321 ↗
24. Muller K. · Biomaterials · 2007 · 28 · 162910.1016/j.biomaterials.2006.12.003 ↗
25. Mykhaylyk O. · Nat. Protoc. · 2007 · 2 · 239110.1038/nprot.2007.352 ↗
26. Lv G. · Langmuir · 2008 · 24 · 215110.1021/la702845s ↗
27. Martin A. L. · Bioconjugate Chem. · 2008 · 19 · 237510.1021/bc800209u ↗
28. Horie M. · Chem. Res. Toxicol. · 2009 · 22 · 141510.1021/tx900171n ↗
29. Wang A. Z. · Chem. Med. Chem. · 2008 · 3 · 131110.1002/cmdc.200800091 ↗
30. Ge Y. · Nanoscale Res. Lett. · 2009 · 4 · 28710.1007/s11671-008-9239-9 ↗
31. Kralj S. · J. Nanopart. Res. · 2011 · 13 · 282910.1007/s11051-010-0171-4 ↗
32. Mahmoudi M. · Colloid Surf. B · 2010 · 75 · 30010.1016/j.colsurfb.2009.08.044 ↗
33. Mahmoudi M. · Nanotechnology · 2009 · 20 · 22510410.1088/0957-4484/20/22/225104 ↗
34. Lee M. · Cancer Res. · 1998 · 58 · 1052
35. Nagata S. · Exp. Cell Res. · 2000 · 256 · 1210.1006/excr.2000.4834 ↗
36. Barkett M. · Oncogene · 1999 · 18 · 691010.1038/sj.onc.1203238 ↗
37. Corcoran C. A. · Cancer Biol. Therapy · 2004 · 3 · 72110.4161/cbt.3.8.1068 ↗
38. Tirone F. · J. Cell. Physiol. · 2001 · 187 · 15510.1002/jcp.1062 ↗
39. Vairapandi M. · J. Cell. Biochem. · 2004 · 91 · 57210.1002/jcb.10749 ↗
40. Yao X. R. · Immunol. Rev. · 1993 · 132 · 16310.1111/j.1600-065X.1993.tb00842.x ↗
41. Badie C. · Br. J. Cancer · 2008 · 98 · 184510.1038/sj.bjc.6604381 ↗
42. Itoh T. · DNA Repair · 2005 · 4 · 145710.1016/j.dnarep.2005.08.008 ↗
43. Kabacik S. · Int. J. Radiat. Biol. · 2010 · 87 · 11510.3109/09553002.2010.519424 ↗
44. Turtoi A. · Int. J. Radiat. Biol. · 2009 · 85 · 40310.1080/09553000902838541 ↗
45. Kevekordes S. · Anticancer Res. · 2001 · 21 · 461
46. Kuo M. L. · Mutat. Res., Genet. Toxcol. Environ. · 1998 · 413 · 14310.1016/S1383-5718(98)00020-5 ↗
47. Lu Y. · Environ. Health Perspect. · 2000 · 108 · 559
48. Uhl M. · Mutat. Res., Genet. Toxicol. Environ. · 1999 · 441 · 21510.1016/S1383-5718(99)00050-9 ↗
49. 10.1016/j.atmosenv.2010.12.02110.1016/j.atmosenv.2010.12.021 ↗
50. Li Y. · Inorg. Chem. Commun. · 2010 · 13 · 121310.1016/j.inoche.2010.07.005 ↗
51. Li Y. · Eur. J. Med. Chem. · 2010 · 45 · 569210.1016/j.ejmech.2010.09.025 ↗
52. Bartosiewicz M. · Environ. Health Perspect. · 2001 · 109 · 7110.1289/ehp.0110971 ↗
53. Kawata K. · Environ. Sci. Technol. · 2007 · 41 · 376910.1021/es062717d ↗
54. Andrew A. S. · Environ. Health Perspect. · 2003 · 111 · 82510.1289/ehp.111-1241504 ↗
55. Forge D. · J. Phys. Chem. C · 2008 · 112 · 1917810.1021/jp803832k ↗
56. Mahmoudi M. · Int. J. Biomed. Nanosci. Nanotechnol. · 2010 · 1 · 16410.1504/IJBNN.2010.034651 ↗
57. Mahmoudi M. · Chem. Rev. · 2011 · 111 · 340710.1021/cr1003166 ↗
58. Forge D. · J. Magn. Magn. Mater. · 2011 · 323 · 41010.1016/j.jmmm.2010.09.031 ↗
59. Barnett, V.; Lewis, T.Outliers in Statistical Data,3rd ed.John Wiley and Sons:New York, 1994; pp584–586.